当前位置：
X-MOL 学术
›
Aliment. Pharm. Ther.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Editorial: optimal combination of non-invasive tests to determine significant fibrosis in non-alcoholic fatty liver disease—authors' reply
Alimentary Pharmacology & Therapeutics ( IF 6.6 ) Pub Date : 2023-05-27 , DOI: 10.1111/apt.17517 Maria Stepanova 1, 2 , Zobair Younossi 2, 3
Alimentary Pharmacology & Therapeutics ( IF 6.6 ) Pub Date : 2023-05-27 , DOI: 10.1111/apt.17517 Maria Stepanova 1, 2 , Zobair Younossi 2, 3
Affiliation
This article is linked to Younossi et al papers. To view these articles, visit https://doi.org/10.1111/apt.17472 and https://doi.org/10.1111/apt.17505
中文翻译：
社论：确定非酒精性脂肪肝病显着纤维化的非侵入性测试的最佳组合——作者的回复
本文链接到 Younossi 等人的论文。要查看这些文章，请访问 https://doi.org/10.1111/apt.17472 和 https://doi.org/10.1111/apt.17505
更新日期：2023-05-30
中文翻译：
社论：确定非酒精性脂肪肝病显着纤维化的非侵入性测试的最佳组合——作者的回复
本文链接到 Younossi 等人的论文。要查看这些文章，请访问 https://doi.org/10.1111/apt.17472 和 https://doi.org/10.1111/apt.17505
京公网安备 11010802027423号